Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-028539
Filing Date
2005-05-26
Accepted
2005-05-26 19:42:51
Documents
1
Period of Report
2005-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4591
  Complete submission text file 0001209191-05-028539.txt   6380
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Issuer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 75 CAMBRIDGE PARKWAY #E1205 CAMBRIDGE MA 02142
Business Address
DAVIE JOSEPH MD PHD (Reporting) CIK: 0001216660 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23930 | Film No.: 05861363